LENZ Therapeutics, Inc.
LENZ
$28.88
$0.3651.28%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 209.03M | 217.11M | 196.11M | 213.28M | 65.79M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 2.77M | 3.48M | 3.12M | 3.28M | 1.45M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 114.00K | 114.00K | 114.00K | 114.00K | -- |
Total Current Assets | 211.92M | 220.70M | 199.35M | 216.67M | 67.24M |
|
|||||
Total Current Assets | 211.92M | 220.70M | 199.35M | 216.67M | 67.24M |
Net Property, Plant & Equipment | 1.99M | 1.91M | 1.89M | 627.00K | 372.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.40M | 1.40M | 1.40M | 21.00K | 2.76M |
Total Assets | 215.30M | 224.01M | 202.64M | 217.32M | 70.38M |
|
|||||
Total Accounts Payable | 4.26M | 2.76M | 4.41M | 7.13M | 5.71M |
Total Accrued Expenses | 5.58M | 4.32M | 3.53M | 11.32M | 12.67M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 567.00K | 625.00K | 649.00K | 433.00K | 137.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 10.41M | 7.71M | 8.58M | 18.89M | 18.51M |
|
|||||
Total Current Liabilities | 10.41M | 7.71M | 8.58M | 18.89M | 18.51M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 814.00K | 953.00K | 1.05M | 156.00K | 192.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | 64.00K | 83.00K | 111.00K | 121.00K |
Total Liabilities | 11.22M | 8.73M | 9.72M | 19.16M | 18.83M |
|
|||||
Common Stock & APIC | 348.90M | 347.12M | 315.13M | 310.06M | 8.43M |
Retained Earnings | -145.01M | -132.36M | -122.15M | -111.89M | -95.25M |
Treasury Stock & Other | 196.00K | 523.00K | -62.00K | -1.00K | 6.00K |
Total Common Equity | 204.08M | 215.28M | 192.92M | 198.17M | -86.81M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | 137.49M |
Preferred Stock, Others | -- | -- | -- | -- | 871.00K |
Total Preferred Equity | -- | -- | -- | -- | 138.36M |
|
|||||
Total Common Equity | 204.08M | 215.28M | 192.92M | 198.17M | -86.81M |
Total Preferred Equity | -- | -- | -- | -- | 138.36M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 204.08M | 215.28M | 192.92M | 198.17M | 51.55M |
|